Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Therapeutic Potential Of M@B 40 (M = Mg and Ca) Fullerene as a Drug Delivery System for Gemcitabine Anti‐Lung Cancer Drug: A DFT Approach

View through CrossRef
Abstract In this research work, we employed density functional theory (DFT) calculations both in gas and aqueous environment to examine the gemcitabine drug delivery efficacy of M@B 40 (M = Mg and Ca) fullerene. The outcomes revealed that gemcitabine tends to bind through its double bonded O group to the boron atom of Mg@B 40 and Ca@B 40 fullerenes, resulting with significant adsorption energies. QTAIM analysis is utilized to clarify the interaction between the fullerene and gemcitabine complex, uncovering the existence of partial covalent interactions. The NBO and MEP analyses provides additional support for the interaction and significant charge transfer occurring between the gemcitabine drug and M@B 40 (M = Mg and Ca) fullerene. The drug loading capacity of both metal‐encapsulated B 40 fullerene is high, as they can accommodate up to five gemcitabine drug molecules. The drug release process and recovery time calculations are also conducted to facilitate the rapid desorption of the drug from the carrier. These findings offer valuable insights into the potential applications of M@B 40 (M = Mg and Ca) fullerene in the realm of drug delivery within the biological systems.
Title: Therapeutic Potential Of M@B 40 (M = Mg and Ca) Fullerene as a Drug Delivery System for Gemcitabine Anti‐Lung Cancer Drug: A DFT Approach
Description:
Abstract In this research work, we employed density functional theory (DFT) calculations both in gas and aqueous environment to examine the gemcitabine drug delivery efficacy of M@B 40 (M = Mg and Ca) fullerene.
The outcomes revealed that gemcitabine tends to bind through its double bonded O group to the boron atom of Mg@B 40 and Ca@B 40 fullerenes, resulting with significant adsorption energies.
QTAIM analysis is utilized to clarify the interaction between the fullerene and gemcitabine complex, uncovering the existence of partial covalent interactions.
The NBO and MEP analyses provides additional support for the interaction and significant charge transfer occurring between the gemcitabine drug and M@B 40 (M = Mg and Ca) fullerene.
The drug loading capacity of both metal‐encapsulated B 40 fullerene is high, as they can accommodate up to five gemcitabine drug molecules.
The drug release process and recovery time calculations are also conducted to facilitate the rapid desorption of the drug from the carrier.
These findings offer valuable insights into the potential applications of M@B 40 (M = Mg and Ca) fullerene in the realm of drug delivery within the biological systems.

Related Results

Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
Abstract 1658: Gemcitabine impacts expression of antigen presentation proteins by pancreatic cancer cells
Abstract 1658: Gemcitabine impacts expression of antigen presentation proteins by pancreatic cancer cells
Abstract Background: Pancreatic adenocarcinoma is one of the deadliest type of cancers with a 5-year overall survival rate of 10%. A standard chemotherapy approach f...
Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
Aptamer–Gemcitabine Conjugates with Enzymatically Cleavable Linker for Targeted Delivery and Intracellular Drug Release in Cancer Cells
Gemcitabine is a chemotherapeutic used clinically to treat a variety of cancers. However, because it lacks tumor cell specificity, gemcitabine may cause off-target cytotoxicity and...
Abstract 1427: Investigating role of RECQ1 in response to gemcitabine treatment in triple negative breast cancer
Abstract 1427: Investigating role of RECQ1 in response to gemcitabine treatment in triple negative breast cancer
Abstract The response of cancer cells to therapeutic drugs aimed at causing DNA damage is dependent on proteins that play roles in DNA repair. Single nucleotide poly...
Ameliorative Role of Grape Seed Extract (Vitis Vinifera) on Gemcitabine- Induced Testicular Damage in Rabbits
Ameliorative Role of Grape Seed Extract (Vitis Vinifera) on Gemcitabine- Induced Testicular Damage in Rabbits
Spermatogenesis is a highly conserved and regulated process and it is sensitive to fluctuations in the physical and chemical environment. Gemcitabine is a novel antimetabolic antic...
Abstract 1828: Development and evaluation of novel gemcitabine analog for the treatment of pancreatic cancer
Abstract 1828: Development and evaluation of novel gemcitabine analog for the treatment of pancreatic cancer
Abstract Purpose: Gemcitabine acts against pancreatic cancer and a wide range of solid tumors and it is known to be rapidly deaminated or metabolized in the blood to...

Back to Top